and knowledge translation experts who study health services solutions to reduce the burden of CKD and other chronic diseases. His work is funded by provincial and national research organizations including the Canadian Institutes of Health Research (CIHR). He reviews regularly for the major general medical and nephrology journals, including The Lancet, JAMA, BMJ, and Kidney International. He has over 100 peer-reviewed scientific publications. A major substantive contribution he has made involved translating clinical research into practice and facilitating understanding of clinical practice guidelines. Dr. Bello was a co-author of the 2015 Canadian Society of Nephrology commentary on the KDIGO [Kidney Disease: Improving Global Outcomes] clinical practice guideline for CKD evaluation and management that contextualizes the global CKD management guideline for the Canadian health system. One issue that arose during the development of the commentary was the lack of an effective mechanism to monitor uptake of guidelines in primary care, where > 90% of patients with CKD are managed. Dr. Bello subsequently partnered with the Canadian Primary Care Sentinel Surveillance Network (CPCSSN) to establish a CKD surveillance system in Canadian primary care in collaboration with existing platforms (CDC CKD Surveillance in the United States and National CKD Audit teams in the United Kingdom) and national networks such as the Canadian Society of Nephrology, CANN-NET (Canadian Kidney Knowledge Translation and Generation Network), and Can-SOLVE CKD (Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease). He is keenly interested in global health initiatives to improve nephrology practice and education in emerging nations. He is currently a Co-Chair for the International Society of Nephrology (ISN) Global Kidney Health Atlas Project; an initiative for capturing the kidney health care status across all regions and countries of the world to facilitate the development and implementation of strategies to enhance global equity in kidney care. End-stage kidney disease (ESKD) represents an advanced stage of CKD with an irreversible loss of kidney function, leading to a need for kidney replacement therapy (KRT). The global burden of ESKD is significant due to high treatment costs and extensive impacts on patient health and well-being. While a variety of treatment options exist, little is known about how access to treatment and characteristics of treatment delivery (e.g., quality indicators, funding mechanisms) vary around the globe. Additionally, the current scope of kidneyspecific health information systems (i.e., registries, electronic health records) is unknown. Lastly, in light of multiple competing health priorities worldwide, it is important to understand variations in government prioritization and strategic planning processes to bridge policies and opportunities where appropriate. This Global Kidney Health Atlas (GKHA) is the outcome of an ISN initiative aimed at closing these knowledge gaps and coordinating efforts to facilitate the delivery of optimal ESKD care worldwide. Objectives: 1. To provide a high-level overview of the burden of ESKD as well as the current state of ESKD care and how it is organized and structured around the world. 2. To conduct a comparative analysis of the capacity to deliver care across countries and regions in order to identify key strengths and weaknesses of various systems and explore opportunities for regional networking and collaboration to improve ESKD care. 3. To provide an advocacy tool to engage major stakeholders (e.g.,WHO, World Bank, UN, OECD, European Union, individual country governments) to support the expansion of available services for ESKD care. ABSTRACT Background Desk Research In collaboration with an expert librarian, we conducted a two-part comprehensive search of government reports, academic research, and gray literature to synthesize the most current epidemiological data on the burden and treatment of ESKD. This literature search set the context for a groundbreaking detailed survey of key stakeholders. GKHA Survey To facilitate an understanding of how capacity for kidney care varies over time and between countries, the GKHA provides concise, relevant, and synthesized information on the delivery of care across different health systems. Together, these components of the GKHA provide a global perspective of the prevalence and incidence of treated ESKD, such as hemodialysis (HD), Methods 14 | Abstract ISN Global Kidney Health Atlas | 2019 Objective Methods/ approach Coverage/ elements Primary data sources Secondary data sources To obtain a snapshot of individual country and regional health system characteristics, and specific elements relevant to ESKD care n Survey n WHO UHC Domains1 n Survey data n Interviews n WHO Global Observatory n UN, World Bank and OECD reports on NCDs n Published data/reports To obtain data on relevant ESKD treatment epidemiology (HD, PD, transplantation) across countries and regions n Scoping review n Estimates for ESKD incidence and prevalence n Estimates for KRT cost n Survey data n Interviews n Systematic reviews and consortia publications n World Health Report n World Health Indicators n Global NCD Repository n IDF Diabetes Atlas n WHF World Cardiovascular Disease